Pharmaceuticals and Life Sciences Archives - Studio Legale De Berti Jacchia Franchini Forlani

PIETRO MEDA NEW PARTNER IN DE BERTI JACCHIA

marketude July 15, 2024 Automotive, Fashion and Luxury, Francesca Zironi, In the Press, Leisure, Sports, Sponsoring and Tourism, Litigation, M&A, Media and Entertainment, Pharmaceuticals and Life Sciences, Pietro Meda, Roberto A. Jacchia

Pietro Meda, a Supreme Court lawyer expert in corporate law and M&A, with a particular focus on the pharmaceutical, real estate, automotive, and e-sports sectors, joins De Berti Jacchia as a partner in the Milan office.

MEDICINALI PER USO UMANO. L’AG EMILIOU SI PRONUNCIA SUI CRITERI PER LA VALUTAZIONE DELLE CONDIZIONI DI RILASCIO DI UN CPC

marketude June 13, 2024 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Litigation, Pharmaceuticals and Life Sciences

GRAIL/ILLUMINA. L’AG EMILIOU SI PRONUNCIA SULLA SENTENZA DEL TRIBUNALE DELL’UNIONE EUROPEA

marketude April 29, 2024 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

LA COMMISSIONE APPROVA LA CESSIONE DELLA GRAIL DA PARTE DELLA ILLUMINA

marketude April 18, 2024 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

LEADERS LEAGUE: RANKED FIRM 2024

marketude April 5, 2024 Antonella Terranova, Arbitration and ADR, Awards, Corporate and Commercial, David Maria Santoro, Employment and Pensions, EU and Competition, Gaspare Roma, Guido Callegari, In the Press, Intellectual Property, Litigation, Maria Cristina Franchini, Michelangelo Cicogna, Pharmaceuticals and Life Sciences, Roberto A. Jacchia

[br]

VENDITA ONLINE DI MEDICINALI NON SOGGETTI A PRESCRIZIONE. LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLE CONDIZIONI ALLE QUALI UNO STATO MEMBRO PUÒ VIETARE UN SERVIZIO CHE METTE IN CONTATTO FARMACISTI E CLIENTI

marketude March 6, 2024 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

RESPONSABILITÀ DA FARMACO: DE BERTI JACCHIA VINCE ANCORA PER GLAXOSMITHKLINE

marketude March 5, 2024 David Maria Santoro, In the Press, Litigation, Pharmaceuticals and Life Sciences

Anche davanti alla Corte d’Appello, la difesa di GlaxoSmithKline spa e della sua collegata SmithKline Beecham plc, coordinati dal Responsabile Affari Legali di GlaxoSmithKline spa, Andrea de Min, era affidata a David Maria Santoro, partner di De Berti Jacchia.

MEDICINALI PER USO UMANO. LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLE MISURE PROVVISORIE ORDINATE SULLA BASE DI UN CPC E SULLA LORO SUCCESSIVA REVOCA

marketude January 16, 2024 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

PAYBACK SUI DISPOSITIVI: IL DIFFICILE RAPPORTO CON LA COSTITUZIONE

marketude December 21, 2023 Administrative and Public Law, Antonella Terranova, In the Press, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] Administrative and Public Law, Pharmaceuticals and Life Sciences

LA CORTE DI GIUSTIZIA SI PRONUNCIA SULL’IMPORTAZIONE DI UN PRODOTTO SANITARIO IN UNO STATO MEMBRO SULLA BASE DI UN PERMESSO DI COMMERCIO PARALLELO

marketude December 14, 2023 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Litigation, Pharmaceuticals and Life Sciences

DATI PERSONALI. LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLA VERIFICA DELLA VALIDITÀ DEI “CERTIFICATI COVID DIGITALI DELL’UE”

marketude November 23, 2023 Coronavirus, Data Protection and Cybersecurity, EU and Competition, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Data Protection and Cybersecurity, Pharmaceuticals and Life Sciences

CARTELLO NEL SETTORE FARMACEUTICO. LA COMMISSIONE SANZIONA 5 IMPRESE

marketude October 26, 2023 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

LUCA PESCATORE NEW PARTNER AT DE BERTI JACCHIA

marketude October 16, 2023 Antonella Terranova, Arbitration and ADR, Automotive, Construction, Corporate and Commercial, In the Press, Insolvency and Restructuring, IT & TMT, Litigation, Luca Pescatore, Pharmaceuticals and Life Sciences, Roberto A. Jacchia

Luca Pescatore joins De Berti Jacchia as a partner in the Rome office.

NUOVE RACCOMANDAZIONI SUGLI ANTIBIOTICI. L’UNIONE EUROPEA SI PREPARA ALL’INVERNO

marketude July 28, 2023 EU and Competition, Federico Aluigi, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] Eu and Competition, Pharmaceuticals and Life Sciences, Perspectives

CALA IL SIPARIO SULL’ACQUISIZIONE GRAIL/ILLUMINA. LA COMMISSIONE SANZIONA LE DUE IMPRESE PER AVER VIOLATO L’OBBLIGO DI STANDSTILL

marketude July 27, 2023 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

ALIMENTI A FINI MEDICI SPECIALI, MEDICINALI ED INTEGRATORI ALIMENTARI RIVISITATI IN UNA RECENTE SENTENZA DELLA CORTE DI GIUSTIZIA

marketude July 24, 2023 Agri-Food, EU and Competition, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Agri-Food, Pharmaceuticals and Life Sciences, Perspectives

LA DECISIONE G 2/21 DELL’ ENLARGED BOARD OF APPEAL DELL’EPO. ALTEZZA INVENTIVA, PLAUSIBILITÀ E DATI POST-PUBBLICATI. IL CASO DEI CPC PER I MEDICINALI DI COMBINAZIONE E LE POSSIBILI DISCRASIE RISPETTO ALLA GIURISPRUDENZA DELLA CORTE DI GIUSTIZIA

marketude July 19, 2023 Agri-Food, Intellectual Property, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] Intellectual Property, Agri-Food, Pharmaceuticals and Life Sciences

LE “PERSONE QUALIFICATE” NELL’INDUSTRIA FARMACEUTICA: QUADRI O DIRIGENTI?

marketude July 18, 2023 Employment and Pensions, Gaspare Roma, In the Press, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] Employment and Pensions, Pharmaceuticals and Life Sciences

I SUPER AVVOCATI E I SUPER STUDI LEGALI CORPORATE 2023

marketude July 10, 2023 Administrative and Public Law, Andrea Sonino, Antonella Terranova, Awards, Banking and Finance, Claudio Corba Colombo, Corporate and Commercial, David Maria Santoro, Employment and Pensions, EU and Competition, Fabio Ferraro, Gaspare Roma, Giuseppe Cristiano, Guido Callegari, In the Press, Litigation, M&A, Marco Frazzica, Massimiliano Gazzo, Michelangelo Cicogna, Pharmaceuticals and Life Sciences, Roberto A. Jacchia, Tax, Tiziana Zona

[br]

LEADERS LEAGUE: RANKED FIRM 2023

marketude July 6, 2023 Antonella Terranova, Arbitration and ADR, Awards, Corporate and Commercial, David Maria Santoro, Employment and Pensions, EU and Competition, Gaspare Roma, Guido Callegari, In the Press, Intellectual Property, Litigation, Maria Cristina Franchini, Michelangelo Cicogna, Pharmaceuticals and Life Sciences, Roberto A. Jacchia

[br]

MEDICINALI PER USO UMANO. LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLE NOZIONI DI “IMPRESA FARMACEUTICA” E DI “PRODOTTI RIVALI”

marketude July 5, 2023 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

QUALIFIED PERSON: RUOLO, RESPONSABILITÀ E IMPATTO DELLE NOVITÀ GMP – Milan, May 25th, 2023

marketude May 25, 2023 Employment and Pensions, Events, Gaspare Roma, Pharmaceuticals and Life Sciences

[x_icon type="map-marker"] Milan[br]
[x_icon type="calendar"] May 25th, 2023[br]
[x_icon type="user"] Gaspare Roma

LE PROPOSTE DELLA COMMISSIONE PER UNA LEGISLAZIONE FARMACEUTICA PIÙ MODERNA E ADEGUATA ALLE ESIGENZE DEI PAZIENTI

marketude May 12, 2023 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

CONTROLLO DELLE CONCENTRAZIONI TRA IMPRESE. LA CORTE DI GIUSTIZIA SI PRONUNCIA SULL’APPLICAZIONE ESCLUSIVA DEL REGOLAMENTO 139/2004 ALLE OPERAZIONI RIENTRANTI NELLA NOZIONE DI “CONCENTRAZIONE”

marketude March 23, 2023 EU and Competition, Litigation, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences

[x_icon type="tag"] EU and Competition, Litigation, Perspectives

LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLA DECISIONE DELL’EMA RECANTE DINIEGO DI CONVALIDA DELLA DOMANDA DI AUTORIZZAZIONE ALL’IMMISSIONE IN COMMERCIO DI UN MEDICINALE PER USO UMANO

marketude March 22, 2023 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

MEDICINALI PER USO UMANO. LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLA CLASSIFICAZIONE COME “DISPOSITIVO MEDICO” O “MEDICINALE”

marketude February 2, 2023 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Litigation, Pharmaceuticals and Life Sciences

MEDICINAL PRODUCTS FOR HUMAN USE. THE COURT OF JUSTICE OF THE EU RULES ON THE ADVERTISING BY PRICE OF MEDICINAL PRODUCTS NOT SUBJECT TO MEDICAL PRESCRIPTION AND NOT REIMBURSED

marketude January 24, 2023 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] Eu and Competition, Litigation, Pharmaceuticals and Life Sciences

MEDICINALI PER USO UMANO. LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLA PUBBLICITÀ CHE INCORAGGIA L’ACQUISTO DI MEDICINALI NON SOGGETTI A PRESCRIZIONE MEDICA E NON RIMBORSABILI FACENDO LEVA SUL LORO PREZZO

marketude January 12, 2023 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] Eu and Competition, Pharmaceuticals and Life Sciences, Litigation

MEDICINALI PER USO UMANO. LA CORTE DI GIUSTIZIA SI PRONUNCIA SUL BLOCCO DEI PREZZI DI TUTTE LE SPECIALITÀ O DI CERTE LORO CATEGORIE

marketude January 11, 2023 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] Eu and Competition, Pharmaceuticals and Life Sciences, Litigation

MEDICINALI PER USO UMANO. LA CORTE DI GIUSTIZIA SI PRONUNCIA SUL DIRITTO DEL TITOLARE DEL MARCHIO DI UN MEDICINALE DI RIFERIMENTO E DI QUELLO DI UN MEDICINALE GENERICO AD OPPORSI ALL’IMMISSIONE IN COMMERCIO DI QUEST’ULTIMO

marketude November 30, 2022 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

MEDICINALI PER USO UMANO. LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLA RIAPPOSIZIONE DEL MARCHIO DEL TITOLARE SPECIFICO DEL PRODOTTO AD ESCLUSIONE DEGLI ALTRI MARCHI O SEGNI DISTINTIVI FIGURANTI SU QUESTO IMBALLAGGIO ESTERNO D’ORIGINE

marketude November 29, 2022 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

MEDICINALI PER USO UMANO. LA CORTE DI GIUSTIZIA SI PRONUNCIA SUL RICONFEZIONAMENTO IN UN NUOVO IMBALLAGGIO E SULLA RIETICHETTATURA DI MEDICINALI IMPORTATI PARALLELAMENTE

marketude November 25, 2022 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

MEDICINALI PER USO UMANO. LA CORTE DI GIUSTIZIA SI PRONUNCIA SUGLI EFFETTI BENEFICI CONCRETI SULLA SALUTE UMANA

marketude October 19, 2022 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

ABUSO DI POSIZIONE DOMINANTE NEL MERCATO DEI FARMACI CONTRO LA SCLEROSI MULTIPLA. LA COMMISSIONE INVIA UNA COMUNICAZIONE DEGLI ADDEBITI ALLA TEVA

marketude October 17, 2022 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

ABUSO DI POSIZIONE DOMINANTE NEL MERCATO DEI FARMACI A BASE DI CDCA. L’AUTORITÀ GARANTE DELLA CONCORRENZA E DEL MERCATO SANZIONA IL GRUPPO LEADIANT

marketude October 13, 2022 Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Society

[x_icon type="tag"] Pharmaceuticals and Life Sciences, Society, Perspectives

LOTTA AL CORONAVIRUS. LE PROPOSTE DELLA COMMISSIONE PER I PROSSIMI AUTUNNI E INVERNI

marketude October 4, 2022 Coronavirus, Intellectual Property, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] Intellectual Property, Pharmaceuticals and Life Sciences, Perspectives

LA COMMISSIONE PONE IL VETO ALL’ACQUISIZIONE DELLA SOCIETÀ GRAIL

marketude October 4, 2022 EU and Competition, Fabio Ferraro, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

NUOVO CAPITOLO NELLA VICENDA GRAIL/ILLUMINA. LA COMMISSIONE INVIA UNA NUOVA COMUNICAZIONE DEGLI ADDEBITI

marketude September 1, 2022 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

SANGUE, TESSUTI E CELLULE. LE PROPOSTE DELLA COMMISSIONE PER UN NUOVO QUADRO NORMATIVO PIÙ SICURO E RIGOROSO

marketude August 29, 2022 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

GRAIL/ILLUMINA. IL TRIBUNALE DELL’UNIONE EUROPEA SI PRONUNCIA SUL PRIMO RINVIO EX ARTICOLO 22 DEL REGOLAMENTO SULLE CONCENTRAZIONI A VALLE DELLE NUOVE LINEE GUIDA

marketude August 2, 2022 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

DE BERTI JACCHIA VINCE AL TRIBUNALE DI SALERNO PER GLAXOSMITHKLINE

marketude July 29, 2022 David Maria Santoro, In the Press, Litigation, Pharmaceuticals and Life Sciences

De Berti Jacchia, con il partner David Maria Santoro, ha assistito con successo GlaxoSmithKline S.p.A. e GlaxoSmithKline Biologicals S.A. davanti al Tribunale di Salerno, in una delicata controversia in tema di responsabilità da prodotto farmaceutico.

DE BERTI JACCHIA WITH CHARGEURS IN THE ACQUISITION OF SKIRA WITH GITTI AND PARTNERS

marketude July 28, 2022 Andrea Sonino, Arbitration and ADR, Benedetta Mazzotti, Claudio Corba Colombo, Employment and Pensions, Fashion and Luxury, In the Press, M&A, Michelangelo Cicogna, Pharmaceuticals and Life Sciences, Rachele Maggi

De Berti Jacchia team – which assisted Chargeurs Museum Solutions on all legal aspects of the transaction – was headed by the partners Michelangelo Cicogna and Claudio Corba Colombo, assisted by the employment partner Andrea Sonino and the senior associates Rachele Maggi and Benedetta Mazzotti.

LA CORTE DI GIUSTIZIA METTE LA PAROLA FINE ALLA SAGA AVASTIN/LUCENTIS

marketude July 21, 2022 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

RUSSIAN GOVERNMENT ISSUES NEW EXPORT WAIVER FOR PHARMA PATENT, ADMITTEDLY RELYING ON ARTICLE 31 BIS OF THE TRIPS AGREEMENT

marketude July 8, 2022 Alisa Pestryakova, Intellectual Property, Pharmaceuticals and Life Sciences, Publications, Russia, Russian Brief

[x_icon type="tag"] Intellectual Property, Pharmaceuticals and Life Sciences, Russia

DE BERTI WITH EA PHARMA IN THE ACQUISITION OF STARDEA

marketude July 5, 2022 Andrea Sonino, Arbitration and ADR, Benedetta Mazzotti, Claudio Corba Colombo, Employment and Pensions, In the Press, Isabella Basilico, M&A, Michelangelo Cicogna, Pharmaceuticals and Life Sciences

De Berti Jacchia team – which assisted EA Pharma on all legal aspects, structuring and coordinating the overall transaction – was headed by the Dispute and Employment partner Michelangelo Cicogna, together with the M&A partner Claudio Corba Colombo, assisted by the employment partner Andrea Sonino and the senior associates Benedetta Mazzotti and Isabella Basilico.

ABUSO DI POSIZIONE DOMINANTE NEL MERCATO DEI FARMACI A BASE DI FERRO. LA SVIZZERA VIFOR PHARMA SOTTO INDAGINE DA PARTE DELLA COMMISSIONE

marketude June 24, 2022 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

PROPRIETÀ INTELLETTUALE E VACCINI CONTRO IL CORONAVIRUS. LA DECISIONE DELLA WTO SULLA SOSPENSIONE TEMPORANEA DEI MONOPOLI BREVETTUALI PER I VACCINI

marketude June 23, 2022 Coronavirus, Intellectual Property, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] Intellectual Property, Pharmaceuticals and Life Sciences, Perspectives

TRASPARENZA NELLE RELAZIONI TRA IMPRESE FARMACEUTICHE ED HEALTHCARE PROFESSIONALS. ENTRA IN VIGORE IL C.D. “SUNSHINE ACT”

marketude June 15, 2022 Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] Pharmaceuticals and Life Sciences, Society, Perspectives

IL REGOLAMENTO 123/2022 E IL RAFFORZAMENTO DEL MANDATO DELL’EMA

marketude June 4, 2022 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

LA CORTE DI GIUSTIZIA SI PRONUNCIA SUL POTERE DELLE AUTORITÀ GIUDIZIARIE NAZIONALI DI EMETTERE PROVVEDIMENTI DI URGENZA PER PREVENIRE VIOLAZIONI IMMINENTI DEI DIRITTI DI PROPRIETÀ INTELLETTUALE

marketude May 16, 2022 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

LE PRINCIPALI NOVITÀ 2022 DEL CODICE DEONTOLOGICO DI FARMINDUSTRIA

marketude May 13, 2022 Compliance, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] Compliance, Pharmaceuticals and Life Sciences, Perspectives

LICENZE OBBLIGATORIE. LA COMMISSIONE AVVIA UNA NUOVA CONSULTAZIONE PUBBLICA

marketude April 28, 2022 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

CERTIFICATI PROTETTIVI COMPLEMENTARI. LA COMMISSIONE AVVIA UNA NUOVA CONSULTAZIONE PUBBLICA

marketude March 29, 2022 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

MEDICINALI PER USO UMANO. L’AG SZPUNAR SI PRONUNCIA SULLA PUBBLICITÀ CHE INCORAGGIA L’ACQUISTO DI MEDICINALI FACENDO LEVA SUL LORO PREZZO

marketude March 16, 2022 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

L’ACQUISIZIONE GRAIL/ILLUMINA E LE MISURE PROVVISORIE DELLA COMMISSIONE CONFERMANO LA POLICY DI CONTRASTO ALLE PRATICHE DI GUN JUMPING

marketude February 23, 2022 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

IMPORTAZIONE PARALLELA DI MEDICINALI. L’AG SZPUNAR SI PRONUNCIA SUL RICONFEZIONAMENTO DEL PRODOTTO CONTRASSEGNATO DAL MARCHIO E SUI DIRITTI DEL TITOLARE DI QUESTO

marketude February 11, 2022 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

USO IMPROPRIO DI BREVETTI E ANTITRUST NEGLI USA (CASO PHARMAVITE C. BAUSCH & LOMB INCORPORATED E CONSUMER HEALTHCARE)

marketude January 24, 2022 Litigation, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] Pharmaceuticals and Life Sciences, Litigation, Perspectives

SPERIMENTAZIONI CLINICHE. ORAMAI ALLE PORTE L’ENTRATA IN VIGORE DEL NUOVO REGOLAMENTO 536/2014

marketude January 13, 2022 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

FARMACOVIGILANZA. LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLA PROPORZIONALITÀ DI MISURE DI EFFETTO EQUIVALENTE AD UNA RESTRIZIONE QUANTITATIVA IN CASO DI CESSAZIONE AUTOMATICA DELL’AIC PER L’IMPORTAZIONE PARALLELA DI MEDICINALI PER USO UMANO

marketude December 15, 2021 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

GLI AIUTI DI STATO NELLA LOTTA AL CORONAVIRUS E LA SESTA MODIFICA DEL TEMPORARY FRAMEWORK

marketude November 22, 2021 Coronavirus, EU and General Policies, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] Coronavirus, EU and General Policies, Pharmaceuticals and Life Sciences

LA LEGGE ANNUALE PER IL MERCATO E LA CONCORRENZA 2021 ED IL RAFFORZAMENTO DEL SERVIZIO SANITARIO NAZIONALE

marketude November 17, 2021 Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] Pharmaceuticals and Life Sciences, Society, Perspectives

ALTEZZA INVENTIVA, DATI POST-PUBBLICATI E PLAUSIBILITÀ IN UN RECENTE RINVIO ALL’ENLARGED BOARD OF APPEAL DELL’EPO

marketude November 15, 2021 Agri-Food, Intellectual Property, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] Intellectual Property, Pharmaceuticals and Life Sciences, Agri-food

LA LEGGE ANNUALE PER IL MERCATO E LA CONCORRENZA 2021 E IL SETTORE FARMACEUTICO

marketude November 12, 2021 Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] Pharmaceuticals and Life Sciences, Society, Perspectives

MALATTIE RARE. IL NUOVO TESTO UNICO È LEGGE

marketude November 8, 2021 Compliance, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] Pharmaceuticals and Life Sciences, Compliance, Perspectives

LA LEGGE ANNUALE PER IL MERCATO E LA CONCORRENZA 2021 E LE PROPOSTE DELL’AGCM PER IL RAFFORZAMENTO DEL SERVIZIO SANITARIO NAZIONALE

marketude September 24, 2021 Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] Pharmaceuticals and Life Sciences, Society, Perspectives

ACCORDI PAY-FOR-DELAY. IL COMPETITION APPEAL TRIBUNAL BRITANNICO CONFERMA LA DECISIONE DELLA COMPETITION AND MARKETS AUTHORITY IN TEMA DI ABUSO DI POSIZIONE DOMINANTE NEL MERCATO DEI MEDICINALI GENERICI

marketude September 21, 2021 Esmeralda Dedej, EU and Competition, Intellectual Property, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Intellectual Property, Society

LE PROPOSTE DELL’AGCM PER LA RIFORMA DELLA CONCORRENZA NEL SETTORE FARMACEUTICO E IL DISEGNO DI LEGGE PER IL MERCATO 2021

marketude September 20, 2021 Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] Pharmaceuticals and Life Sciences, Society, Perspectives

LA LEGGE ANNUALE PER IL MERCATO E LA CONCORRENZA 2021 E LE SEGNALAZIONI E PROPOSTE DELL’AGCM

marketude September 14, 2021 Esmeralda Dedej, EU and Competition, Pharmaceuticals and Life Sciences, Public Procurement and Tenders, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Public Procurement and Tenders, Society

SCUDO PENALE E OBBLIGO VACCINALE PER IL PERSONALE MEDICO E SANITARIO. LE DISPOSIZIONI ITALIANE E IL CONTESTO EUROPEO

marketude September 3, 2021 Coronavirus, Esmeralda Dedej, Pharmaceuticals and Life Sciences, Product Liability and Safety, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] Coronavirus, Pharmaceuticals and Life Sciences, Product Liability and Safety, Society

ASSICURAZIONI SANITARIE. L’AGCM SANZIONA INTESA SANPAOLO RBM SALUTE E PREVIMEDICAL PER PRATICHE COMMERCIALI SCORRETTE

marketude August 5, 2021 Consumer and Retail, Esmeralda Dedej, EU and Competition, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia, Transport, Insurance and Logistics

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Consumer and Retail, Transport, Insurance and Logistics

L’AUTORITÀ PER I CONSUMATORI E I MERCATI OLANDESE SANZIONA LA LEADIANT PER UN ABUSO DI POSIZIONE DOMINANTE NEL MERCATO DEI MEDICINALI ORFANI

marketude August 2, 2021 Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] Pharmaceuticals and Life Sciences, Society, Perspectives

LEADERS LEAGUE: RANKED FIRM 2021

marketude July 30, 2021 Antonella Terranova, Arbitration and ADR, Awards, Corporate and Commercial, David Maria Santoro, Employment and Pensions, EU and Competition, Gaspare Roma, Guido Callegari, In the Press, Intellectual Property, IT & TMT, Litigation, Maria Cristina Franchini, Michelangelo Cicogna, Pharmaceuticals and Life Sciences, Roberto A. Jacchia

[br]

PRIMO RINVIO EX ARTICOLO 22 DEL REGOLAMENTO EUROPEO SULLE CONCENTRAZIONI. LA COMMISSIONE APRE UN’INDAGINE SULL’ACQUISIZIONE GRAIL/ILLUMINA

marketude July 30, 2021 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

LICENZE OBBLIGATORIE PER I BREVETTI ED EMERGENZE SANITARIE. VIA LIBERA COL NUOVO EMENDAMENTO AL DECRETO RECOVERY

marketude July 28, 2021 Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] Pharmaceuticals and Life Sciences, Society, Perspectives

MEDICINALI PER USO UMANO SOGGETTI A PRESCRIZIONE MEDICA. LIBERA CIRCOLAZIONE DELLE MERCI E DIVIETO DI OFFRIRE, PUBBLICIZZARE O CONCEDERE OMAGGI NELLE VENDITE PER CORRISPONDENZA

marketude July 20, 2021 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

IL FUTURO RUOLO DELL’EMA NELLA REGOLAZIONE DEI DISPOSITIVI MEDICI

marketude July 14, 2021 Esmeralda Dedej, In the Press, Intellectual Property, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] Intellectual Property, Pharmaceuticals and Life Sciences

LA CORTE DI GIUSTIZIA SI PRONUNCIA SULLA CLASSIFICAZIONE NAZIONALE DEI MEDICINALI PER USO UMANO AUTORIZZATI IN UN DIVERSO STATO MEMBRO COME NON SOGGETTI A PRESCRIZIONE MEDICA

marketude July 13, 2021 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

DISPOSITIVI MEDICI. ENTRA IN VIGORE IL REGOLAMENTO 2017/745

marketude June 22, 2021 Esmeralda Dedej, EU and Competition, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

LE PROPOSTE DELLA COMMISSIONE ALLA WTO PER UN PIANO D’AZIONE MULTILATERALE NELLA LOTTA AL CORONAVIRUS

marketude June 7, 2021 Coronavirus, EU and General Policies, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] Coronavirus, Pharmaceuticals and Life Sciences, EU and General Policies, Society, Perspectives

NELLA SENTENZA LUNDBECK LA CORTE DI GIUSTIZIA CONFERMA CHE GLI ACCORDI PAY-FOR-DELAY COSTITUISCONO RESTRIZIONI DELLA CONCORRENZA PER OGGETTO

marketude May 28, 2021 EU and Competition, Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Litigation

Video source missing

SOSPENSIONE DEI BREVETTI SUI VACCINI – RADIO LOMBARDIA – INTERVISTA A ROBERTO A. JACCHIA

marketude May 21, 2021 Coronavirus, EU and Competition, In the Press, Intellectual Property, Pharmaceuticals and Life Sciences, Videos

[br]

LA SOSPENSIONE DEI BREVETTI SUI VACCINI / DIDEROT – LE VOCI DELL’ATTUALITÀ – Radio Live, Rete Due – RSI Radiotelevisione Svizzera, May 17th, 2021

marketude May 17, 2021 Diego Conte, Events, In the Press, Intellectual Property, Massimiliano Gazzo, Pharmaceuticals and Life Sciences, Roberto A. Jacchia, Tax, Videos

[x_icon type="map-marker"] Radio Live, RSI Radiotelevisione Svizzera[br]
[x_icon type="calendar"] May 17th, 2021[br]
[x_icon type="user"] Roberto A. Jacchia

UN ALTRO EPISODIO DELLA SAGA AVASTIN/LUCENTIS. IL NUOVO RINVIO DEL CONSIGLIO DI STATO ALLA CORTE DI GIUSTIZIA

marketude May 12, 2021 Litigation, Marco Stillo, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia, Society

[x_icon type="tag"] Litigation, Pharmaceuticals and Life Sciences, Society

AUTORIZZAZIONE DUPLICATA ALL’IMMISSIONE IN COMMERCIO DI PRODOTTI FARMACEUTICI. LE NUOVE LINEE GUIDA DELLA COMMISSIONE

marketude May 6, 2021 EU and Competition, Marco Stillo, Perspectives, Pharmaceuticals and Life Sciences, Publications, Roberto A. Jacchia

[x_icon type="tag"] EU and Competition, Pharmaceuticals and Life Sciences, Perspectives

GILEAD SCIENCES CHALLENGES THE GRANT BY THE RUSSIAN GOVERNMENT OF THE RIGHT TO USE WITHOUT CONSENT ITS PATENTS FOR MEDICINES EMPLOYED IN THE COVID- 19 THERAPY

marketude April 21, 2021 Alisa Pestryakova, Coronavirus, Intellectual Property, Pharmaceuticals and Life Sciences, Publications, Russia, Russian Brief

[x_icon type="tag"] Coronavirus, Intellectual Property, Pharmaceuticals and Life Sciences, Russia

PASSAPORTO VACCINALE E GDPR: IL PARERE DELLE ISTITUZIONI EUROPEE

marketude April 16, 2021 Adriano Garofalo, Data Protection and Cybersecurity, EU and Competition, In the Press, Pharmaceuticals and Life Sciences, Publications, Society

[x_icon type="tag"] Data Protection and Cybersecurity, EU and Competition, Pharmaceuticals and Life Sciences, Society

DE BERTI JACCHIA VINCE PER GLAXOSMITHKLINE SULLA RESPONSABILITÀ DA PRODOTTI FARMACEUTICI

marketude April 13, 2021 David Maria Santoro, In the Press, Litigation, Pharmaceuticals and Life Sciences

Sono state pubblicate in rapida successione tre decisioni che hanno definito altrettanti procedimenti giudiziari nei quali De Berti Jacchia, con il partner David Maria Santoro, ha assistito con successo GlaxoSmithKline S.p.A. ed altre società collegate dell’omonimo gruppo farmaceutico anglosassone, ritenute responsabili di danni – patrimoniali e non – legati all’impiego di propri prodotti.